Xia X, Liu S, Huang P, Wu Z, Wang P, Xu H, Tan X, Mei E, Hu S
Ophthalmic Laser Center, Xiangya Hospital, Hunan Medical University, Changsha 410008.
Zhonghua Yan Ke Za Zhi. 1999 May;35(3):203-6.
To evaluate the efficacy and safety of reoperation of residual myopia because of regression, undercorrection with or without coexisting severe corneal haze after excimer laser photorefractive keratectomy (PRK).
A VISK 20/20 excimer laser was used to treat myopia of -1.00 to -16.50 diopters (spherical equivalent) at corneal plane. 35 patients (51 eyes) who had residual myopia because of regression, undercorrection with or without coexisting severe corneal haze after initial PRK were retreated by using PRK and phototherapeutic keratectomy.
At 12 months after retreatment, the rates of uncorrected visual acuity more than or equal to 10/20 or 20/20 were 82.6% and 39.1% respectively, 100.0% and 50.0% in myopia up to -6.00 D, 73.3% and 33.3% in myopia of -6.25 to -16.50 D respectively. 86.3% of eyes were within +/- 1.00 diopters of desired emmetropia. Corneal haze after retreatment was not greater than that observed after initial procedures.
The residual myopia because of regression, undercorrection with or without severe corneal haze after initial PRK can be successfully retreated. Although the therapeutic result of retreatment of PRK is less successful than that of the initial procedure, retreatment appears to enhance it.
评估准分子激光屈光性角膜切削术(PRK)后因回退、欠矫伴或不伴严重角膜混浊导致的残余近视再次手术的疗效和安全性。
使用VISK 20/20准分子激光治疗角膜平面上-1.00至-16.50屈光度(等效球镜)的近视。对35例(51只眼)初次PRK后因回退、欠矫伴或不伴严重角膜混浊而存在残余近视的患者,采用PRK和光治疗性角膜切削术进行再次治疗。
再次治疗后12个月,未矫正视力大于或等于10/20或20/20的比例分别为82.6%和39.1%,近视度数达-6.00 D及以下者分别为100.0%和50.0%,-6.25至-16.50 D的近视患者分别为73.3%和33.3%。86.3%的眼屈光状态在预期正视眼的±1.00屈光度范围内。再次治疗后的角膜混浊不大于初次手术时观察到的角膜混浊。
初次PRK后因回退、欠矫伴或不伴严重角膜混浊导致的残余近视可成功再次治疗。虽然再次PRK的治疗效果不如初次手术,但再次治疗似乎能改善疗效。